Solventum
SOLVSolventum is a leading global healthcare company that develops, manufactures, and commercializes a broad portfolio of medical solutions.
Earnings
Next report
Aug 6, 2026 (In 3 weeks)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Solventum is a leading global healthcare company that develops, manufactures, and commercializes a broad portfolio of medical solutions. The company leverages material science, data science, and digital capabilities to improve standards of care across prevention, diagnosis, treatment, and recovery. Its value proposition centers on solving complex clinical challenges through innovation and manufacturing expertise.
Solventum is a leading global player with a 70-year history of innovation and a significant presence in over 90 countries. It maintains a strong competitive position through deep material science expertise and a broad portfolio of well-known brands.
Questions, answered.
- What is Solventum's market cap?
- Solventum (SOLV) has a market capitalization of $13.2B and trades on NYSE.
- What is Solventum's revenue and profitability?
- Solventum generated $8.3B in trailing twelve-month revenue with net income of $1.4B, representing a net margin of 17.3%. Gross margin stands at 53.7%, with free cash flow of -$282.0M. These figures are based on the Q1 2026 filing.
- Who are Solventum's competitors?
- Solventum's key competitors include Envista, Align Technology, Dentsply Sirona, and others. These companies compete in similar markets and product categories.
- Who does Solventum partner with?
- Solventum's notable partners include 3M Company, Microsoft.
- What subsidiaries does Solventum have?
- Solventum's subsidiaries include Acera Surgical.
- Where is Solventum headquartered?
- Solventum is headquartered in United States of America and employs approximately 22,000 people. It has been publicly traded since 2024.
